Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- CheckyesterdayChange DetectedRevision: v3.4.1 appears to replace the prior v3.4.0 without altering core study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoChange DetectedThe update adds a 'Show glossary' feature and a footer label 'Revision: v3.4.0', and includes small wording/capitalization tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a comprehensive Locations section listing all study sites by state (Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Washington) and updated the revision tag from v3.3.2 to v3.3.3.SummaryDifference2%

- Check73 days agoChange DetectedThe PubMed publications section text was updated to state that entries are auto-filled from PubMed and may not pertain to the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page no longer shows the government funding/NIH operating status notice; other study details and links remain unchanged.SummaryDifference0.3%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.